トラベルワクチン市場規模- 構成、疾患タイプ、用途別、世界予測、 2023-2032

トラベルワクチン市場規模は、麻疹やデング熱を含むいくつかの新たな感染症の流入と既存の感染症の復活に牽引され、2023年から2032年にかけてCAGR 9.7%を記録する見通しです。

米国疾病対策予防センター（Centers for Disease Control and Prevention）によると、はしかによる死者は2021年に推定12万8,000人、そのほとんどが子どもでした。

既存のトラベルワクチンの改良や新しいワクチンの開発を目的とした研究開発活動や投資も、業界の成長を後押しすると思われます。一例を挙げると、2023年5月、バイエルン・ノルディックは、研究開発と製造能力を強化するため、2億7,400万米ドルを投資してエマージェント・バイオソリューションズのトラベルワクチンポートフォリオを買収しました。より広範囲な予防を提供するため、より簡便な1回接種のワクチン作りに注目が集まっていることも、製品採用に拍車をかけています。

混合ワクチンの構成では、2023年から2032年にかけてのCAGRは高い可能性があります。混合ワクチンは、ワクチン接種プロセスを簡素化し、旅行者のコンプライアンスを高めるために使用されます。これらのワクチンは、複数の予防接種の必要性を制限すると同時に、複数の疾病に対する予防効果を発揮するため、様々な地域で複数の感染症にさらされるリスクのある旅行者にとって特に有益です。必要な注射や予防接種の回数を減らしたいという消費者の嗜好が高まっていることも、この製品の普及に有利に働くと思われます。

疾病タイプ別では、B型肝炎分野のトラベルワクチン市場が2032年まで大きなCAGRを獲得すると予想されます。メディカルツーリズムの急成長に伴い、ヘルスケア施設は患者だけでなくメディカルツーリズムの旅行者にもB型肝炎ワクチンの必要性を強調し、感染拡大を抑制しています。主にアフリカとアジアでB型肝炎の有病率が高いことと、仕事関連の旅行率が上昇していることが、このセグメントの成長を促進すると思われます。WHOの発表によると、2022年には約9,100万人のアフリカ人がB型肝炎またはC型肝炎に感染しています。

地域別では、APACのトラベルワクチン市場規模は、中間層人口の急速な増加と海外旅行志向の高まりにより、2032年まで顕著なCAGRを記録すると予測されています。この地域のいくつかの政府は、入国要件や予防接種証明書など、トラベルワクチンに関する規制を常に見直し、更新しています。また、ヘルスケア機関がトラベルワクチンの重要性を強調していることも、この地域の市場拡大に有利です。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 トラベルワクチン市場洞察

• 業界情勢
• 業界への影響要因
  • 促進要因
    • 旅行・観光客の増加
    • ワクチンで予防可能な病気に対する旅行者の意識の高まり
    • 政府やその他の組織による旅行の安全性向上への取り組み
  • 業界の潜在的リスク＆課題
    • 高額なトラベルワクチン費用
    • トラベルワクチンに伴う副作用
• 成長可能性分析
• COVID-19の影響分析
• 規制状況
• ポーター分析
• PESTEL分析

第4章 競合情勢

• イントロダクション
• 企業マトリックス分析
• 世界企業シェア分析
• 競合ポジショニングマトリックス
• 戦略ダッシュボード

第5章 トラベルワクチン市場：構成別、2018年～2032年

• 主要動向：構成別
• 単独ワクチン
• 混合ワクチン

第6章 トラベルワクチン市場：疾患タイプ別、2018年～2032年

• 主要動向：疾患タイプ別
• A型肝炎
• B型肝炎
• インフルエンザ
• ジフテリア百日咳破傷風（DPT）
• 狂犬病
• 黄熱
• 腸チフス
• 麻疹および流行性耳下腺炎
• 髄膜炎菌
• その他の疾患ワクチン

第7章 トラベルワクチン市場：用途別、2018年～2032年

• 主要動向：用途別
• 海外旅行
• 国内旅行

第8章 トラベルワクチン市場：地域別、2018年～2032年

• 主要動向：地域別
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • その他中東とアフリカ

第9章 企業プロファイル

• GSK plc
• Sanofi
• Janssen Pharmaceuticals Inc.
• Pfizer Inc.
• CSL Ltd.
• Qiagen N.V.
• AstraZeneca
• F. Hoffmann-La Roche Ltd
• Abbott Laboratories
• Valneva Inc

Data Tables

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by composition (2022)
• TABLE 3 Market revenue, by disease type (2022)
• TABLE 4 Market revenue, by application (2022)
• TABLE 5 Market share, by region (2022)
• TABLE 6 Global travel vaccines market size, by region, 2018 - 2022 (USD Million)
• TABLE 7 Global travel vaccines market size, by region, 2023 - 2032 (USD Million)
• TABLE 8 Global travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 9 Global travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 10 Global travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 11 Global travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 12 Global travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 13 Global travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 14 Industry impact forces
• TABLE 15 Mono vaccines market size, by region, 2018 - 2022 (USD Million)
• TABLE 16 Mono vaccines market size, by region, 2023 - 2032 (USD Million)
• TABLE 17 Combination vaccines market size, by region, 2018 - 2022 (USD Million)
• TABLE 18 Combination vaccines market size, by region, 2023 - 2032 (USD Million)
• TABLE 19 Hepatitis A market size, by region, 2018 - 2022 (USD Million)
• TABLE 20 Hepatitis A market size, by region, 2023 - 2032 (USD Million)
• TABLE 21 Hepatitis B market size, by region, 2018 - 2022 (USD Million)
• TABLE 22 Hepatitis B market size, by region, 2023 - 2032 (USD Million)
• TABLE 23 Influenza market size, by region, 2018 - 2022 (USD Million)
• TABLE 24 Influenza market size, by region, 2023 - 2032 (USD Million)
• TABLE 25 Diphtheria pertussis tetanus (DPT) market size, by region, 2018 - 2022 (USD Million)
• TABLE 26 Diphtheria pertussis tetanus (DPT) market size, by region, 2023 - 2032 (USD Million)
• TABLE 27 Rabies market size, by region, 2018 - 2022 (USD Million)
• TABLE 28 Rabies market size, by region, 2023 - 2032 (USD Million)
• TABLE 29 Yellow fever market size, by region, 2018 - 2022 (USD Million)
• TABLE 30 Yellow fever market size, by region, 2023 - 2032 (USD Million)
• TABLE 31 Typhoid market size, by region, 2018 - 2022 (USD Million)
• TABLE 32 Typhoid market size, by region, 2023 - 2032 (USD Million)
• TABLE 33 Measles and mumps market size, by region, 2018 - 2022 (USD Million)
• TABLE 34 Measles and mumps market size, by region, 2023 - 2032 (USD Million)
• TABLE 35 Meningococcal market size, by region, 2018 - 2022 (USD Million)
• TABLE 36 Meningococcal market size, by region, 2023 - 2032 (USD Million)
• TABLE 37 Other disease vaccines market size, by region, 2018 - 2022 (USD Million)
• TABLE 38 Other disease vaccines market size, by region, 2023 - 2032 (USD Million)
• TABLE 39 Outbound travel vaccines market size, by region, 2018 - 2022 (USD Million)
• TABLE 40 Outbound travel vaccines market size, by region, 2023 - 2032 (USD Million)
• TABLE 41 Domestic travel vaccines market size, by region, 2018 - 2022 (USD Million)
• TABLE 42 Domestic travel vaccines market size, by region, 2023 - 2032 (USD Million)
• TABLE 43 North America travel vaccines market size, by country, 2018 - 2022 (USD Million)
• TABLE 44 North America travel vaccines market size, by country, 2023 - 2032 (USD Million)
• TABLE 45 North America travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 46 North America travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 47 North America travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 48 North America travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 49 North America travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 50 North America travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 51 U.S. travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 52 U.S. travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 53 U.S. travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 54 U.S. travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 55 U.S. travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 56 U.S. travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 57 Canada travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 58 Canada travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 59 Canada travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 60 Canada travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 61 Canada travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 62 Canada travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 63 Europe travel vaccines market size, by country, 2018 - 2022 (USD Million)
• TABLE 64 Europe travel vaccines market size, by country, 2023 - 2032 (USD Million)
• TABLE 65 Europe travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 66 Europe travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 67 Europe travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 68 Europe travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 69 Europe travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 70 Europe travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 71 Germany travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 72 Germany travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 73 Germany travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 74 Germany travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 75 Germany travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 76 Germany travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 77 UK travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 78 UK travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 79 UK travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 80 UK travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 81 UK travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 82 UK travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 83 France travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 84 France travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 85 France travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 86 France travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 87 France travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 88 France travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 89 Spain travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 90 Spain travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 91 Spain travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 92 Spain travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 93 Spain travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 94 Spain travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 95 Italy travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 96 Italy travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 97 Italy travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 98 Italy travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 99 Italy travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 100 Italy travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 101 Rest of Europe travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 102 Rest of Europe travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 103 Rest of Europe travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 104 Rest of Europe travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 105 Rest of Europe travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 106 Rest of Europe travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 107 Asia Pacific travel vaccines market size, by country, 2018 - 2022 (USD Million)
• TABLE 108 Asia Pacific travel vaccines market size, by country, 2023 - 2032 (USD Million)
• TABLE 109 Asia Pacific travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 110 Asia Pacific travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 111 Asia Pacific travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 112 Asia Pacific travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 113 Asia Pacific travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 114 Asia Pacific travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 115 China travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 116 China travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 117 China travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 118 China travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 119 China travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 120 China travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 121 Japan travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 122 Japan travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 123 Japan travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 124 Japan travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 125 Japan travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 126 Japan travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 127 India travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 128 India travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 129 India travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 130 India travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 131 India travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 132 India travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 133 Australia travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 134 Australia travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 135 Australia travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 136 Australia travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 137 Australia travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 138 Australia travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 139 Rest of Asia Pacific travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 140 Rest of Asia Pacific travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 141 Rest of Asia Pacific travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 142 Rest of Asia Pacific travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 143 Rest of Asia Pacific travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 144 Rest of Asia Pacific travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 145 Latin America travel vaccines market size, by country, 2018 - 2022 (USD Million)
• TABLE 146 Latin America travel vaccines market size, by country, 2023 - 2032 (USD Million)
• TABLE 147 Latin America travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 148 Latin America travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 149 Latin America travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 150 Latin America travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 151 Latin America travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 152 Latin America travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 153 Brazil travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 154 Brazil travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 155 Brazil travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 156 Brazil travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 157 Brazil travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 158 Brazil travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 159 Mexico travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 160 Mexico travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 161 Mexico travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 162 Mexico travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 163 Mexico travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 164 Mexico travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 165 Rest of Latin America travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 166 Rest of Latin America travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 167 Rest of Latin America travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 168 Rest of Latin America travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 169 Rest of Latin America travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 170 Rest of Latin America travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 171 Middle East & Africa travel vaccines market size, by country, 2018 - 2022 (USD Million)
• TABLE 172 Middle East & Africa travel vaccines market size, by country, 2023 - 2032 (USD Million)
• TABLE 173 Middle East & Africa travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 174 Middle East & Africa travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 175 Middle East & Africa travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 176 Middle East & Africa travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 177 Middle East & Africa travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 178 Middle East & Africa travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 179 South Africa travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 180 South Africa travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 181 South Africa travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 182 South Africa travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 183 South Africa travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 184 South Africa travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 185 Saudi Arabia travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 186 Saudi Arabia travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 187 Saudi Arabia travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 188 Saudi Arabia travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 189 Saudi Arabia travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 190 Saudi Arabia travel vaccines market size, by application, 2023 - 2032 (USD Million)
• TABLE 191 Rest of Middle East & Africa travel vaccines market size, by composition, 2018 - 2022 (USD Million)
• TABLE 192 Rest of Middle East & Africa travel vaccines market size, by composition, 2023 - 2032 (USD Million)
• TABLE 193 Rest of Middle East & Africa travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 194 Rest of Middle East & Africa travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 195 Rest of Middle East & Africa travel vaccines market size, by application, 2018 - 2022 (USD Million)
• TABLE 196 Rest of Middle East & Africa travel vaccines market size, by application, 2023 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Travel vaccines industry 360 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by composition
• FIG 8 Growth potential analysis, by disease type
• FIG 9 Growth potential analysis, by application
• FIG 10 Porter's analysis
• FIG 11 PESTEL analysis
• FIG 12 Company matrix analysis, 2022
• FIG 13 Global company market share analysis, 2022
• FIG 14 Competitive positioning matrix, 2022
• FIG 15 Strategic dashboard, 2022

Travel Vaccines Market size is poised to record 9.7% CAGR from 2023-2032, driven by the influx of several new infectious diseases and the resurgence of existing ones, including measles and dengue. As per the Centers for Disease Control and Prevention, measles killed an estimated 128,000 people, mostly children in 2021.

The ongoing R&D activities and investments aimed at improving the existing travel vaccines and developing new vaccines will also assist the industry growth. To cite an instance, in May 2023, Bavarian Nordic invested $274M to acquire travel vaccine portfolio of Emergent BioSolutions in a bid to strengthen its R&D and manufacturing capabilities. The growing focus on the creation of more convenient, single-dose vaccines to offer broader protection will also add to the product adoption.

The overall travel vaccines industry is segmented based on composition, disease type, application, and region.

In terms of composition, the demand for combination travel vaccines may record appreciable CAGR from 2023-2032. Combination vaccines are used for simplifying the vaccination process and enhance compliance among travelers. These vaccines are especially beneficial for travelers at risk of exposure to several infectious diseases in different regions as they limit the need for multiple vaccinations while rendering protection against multiple diseases. The rising consumer preference for reducing the number of required injections and shots will also prove favorable for the product uptake.

With respect to disease type, the travel vaccines market from the hepatitis B segment is expected to garner significant CAGR through 2032. With the rapid growth in medical tourism, healthcare facilities are highlighting the requirement for hepatitis B vaccines for patients as well as medical tourists to limit the infection transmission. The higher prevalence of hepatitis B, mainly in Africa and Asia along with the rising rate of work-related travel will drive the segment growth. As per the WHO, nearly 91 million Africans were infected with Hepatitis B or C in 2022.

Regionally, APAC travel vaccines market size is projected to record appreciable CAGR through 2032 due to the rapid growth of the middle-class population and the rising preference for international travel. Several governments in the region are constantly reviewing and updating regulations related to travel vaccines, such as entry requirements and vaccination certificates. The surging emphasis laid by healthcare organizations about the importance of travel vaccinations will also prove favorable for the regional market expansion.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Covid-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Secondary
    • 1.6.1.1 Paid sources
    • 1.6.1.2 Public sources
  • 1.6.2 Primary

Chapter 2 Executive Summary

• 2.1 Travel vaccines industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Composition trends
  • 2.1.4 Disease type trends
  • 2.1.5 Application trends

Chapter 3 Travel Vaccines Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing travel & tourism
    • 3.2.1.2 Increasing awareness about vaccine-preventable diseases among travelers
    • 3.2.1.3 Initiatives by governments and other organizations to enhance travel safety
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of travel vaccinations
    • 3.2.2.2 Side effects associated with travel vaccines
• 3.3 Growth potential analysis
  • 3.3.1 By composition
  • 3.3.2 By disease type
  • 3.3.3 By application
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Global company market share analysis, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategic dashboard, 2022

Chapter 5 Travel Vaccines Market, By Composition, 2018 - 2032 (USD Million)

• 5.1 Key trends, by composition
• 5.2 Mono vaccines
• 5.3 Combination vaccines

Chapter 6 Travel Vaccines Market, By Disease Type, 2018 - 2032 (USD Million)

• 6.1 Key trends, by disease type
• 6.2 Hepatitis A
• 6.3 Hepatitis B
• 6.4 Influenza
• 6.5 Diphtheria pertussis tetanus (DPT)
• 6.6 Rabies
• 6.7 Yellow fever
• 6.8 Typhoid
• 6.9 Measles and mumps
• 6.10 Meningococcal
• 6.11 Other disease vaccines

Chapter 7 Travel Vaccines Market, By Application, 2018 - 2032 (USD Million)

• 7.1 Key trends, by application
• 7.2 Outbound travel
• 7.3 Domestic travel

Chapter 8 Travel Vaccines Market, By Region, 2018 - 2032 (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 GSK plc
• 9.2 Sanofi
• 9.3 Janssen Pharmaceuticals Inc.
• 9.4 Pfizer Inc.
• 9.5 CSL Ltd.
• 9.6 Qiagen N.V.
• 9.7 AstraZeneca
• 9.8 F. Hoffmann-La Roche Ltd
• 9.9 Abbott Laboratories
• 9.10 Valneva Inc